Core Viewpoint - The trade friction between China and the U.S. regarding erythritol has reached a critical point, with significant tariffs imposed on Chinese products, impacting market access and prompting companies to diversify their strategies to mitigate risks [2][3][4]. Group 1: Tariff Implications - The U.S. Department of Commerce announced final anti-dumping and countervailing duties on Chinese erythritol products, with a countervailing duty of 8.63% and an anti-dumping duty of 84.95%, resulting in a combined tariff of 93.58% [2][3]. - This combined tariff, although reduced from a previous rate of 450.64%, still poses a significant barrier for Chinese companies seeking to enter the U.S. market [2][3][4]. Group 2: Market Dynamics - The initial investigation began in December 2024, initiated by U.S. producer Cargill, leading to a significant drop in Chinese erythritol exports to the U.S. due to high tariffs [3]. - The competitive landscape in the sugar substitute industry remains challenging, with nearly 94% tariffs creating a heavy burden for companies relying solely on raw material exports [4]. Group 3: Strategic Responses - In response to the tariffs, the company is accelerating the production of allulose, a promising new product, with plans for a 20,000-ton annual production capacity, which is expected to meet growing demand in the U.S. and other markets [7][8]. - The company is also diversifying its product offerings by developing high-value products such as rebaudioside M and sweet tea glycosides, as well as cosmetic raw materials, to reduce reliance on erythritol [8]. - To counteract the challenges in the U.S. market, the company is expanding into neighboring markets like Canada and Mexico, and is also addressing raw material cost issues by building a corn processing line [8].

Group 1: Livestock Industry - The pig industry is currently in a phase of deep losses, with supply contraction expected to continue into the first half of 2026, leading to a significant reduction in production capacity. The average pig price for 2025 is projected to be below the cost line, with quarterly estimates of 15.5 CNY/kg, 13.5 CNY/kg, 16.4 CNY/kg, and 17.7 CNY/kg, resulting in an annual average of approximately 13.4 CNY/kg [11][25][26] - The white chicken market is experiencing a cautious outlook, with a projected supply growth of less than 5% for 2026. The decline in the sales of commodity broiler chicks indicates a more conservative price expectation within the industry [30][35] - The yellow chicken sector remains stable, with production capacity not significantly affected. The prices are expected to follow trends in other protein sources, with a focus on seasonal price increases [39] - The beef market is anticipated to see a price increase due to a clear reduction in both domestic and international supply. The wholesale price of beef has been rising, reaching 66.21 CNY/kg in December, reflecting a year-on-year increase of 9.1% [42][70] Group 2: Agricultural Inputs and Other Sectors - The feed industry is showing signs of recovery, with a 6.6% year-on-year increase in feed production for the first three quarters of 2025, indicating improved demand from the livestock sector [71][76] - The edible mushroom sector is witnessing a rebound, particularly with the reversal of the predicament faced by enoki mushrooms and the potential growth of new products like Cordyceps [3][80] - The pet industry continues to thrive, with a notable trend towards high-end domestic products, as evidenced by the performance of brands like Guibao Pet and Zhongchong Co. [4][63] - The natural sweetener market is expected to grow as consumer awareness of sugar reduction increases, with companies like Bailong Chuangyuan and Baolingbao positioned to benefit from this trend [4][71]

保龄宝2024年实现总营业收入24亿元，同比减少4.8%；实现归母净利润1.1亿元，同比增长106%，业绩 跌幅也较上年同期好转。 记者注意到，代糖股的业绩回升，主要与2024年赤藓糖醇整体市场改善有关。2024年三元生物赤藓糖醇 业务收入5.2亿元，同比增长26.4%，毛利率从2023年的1.1%上升至2024年的8.3%，带动了整体利润水平 的提升。保龄宝的情况也类似，2024年赤藓糖醇销售收入同比增长52.6%，减糖甜味剂业务毛利率也提 升了7.8个百分点。 在2021年前后，受市场需求激增和利润水平良好的影响，赤藓糖醇迎来一轮扩产潮，到2023年5月，国 内赤藓糖醇产能已达到38万吨/年，远超全球市场的实际需求，过剩也带来了激烈的价格战。赤藓糖醇 的价格从4万元/吨跌至9500元/吨。2024年，随着过剩产能逐步出清和行业整合，赤藓糖醇价格回升， 带动了代糖股的业绩回升。 三元生物称，目前国内赤藓糖醇行业的竞争格局有所缓解，但市场价格尚未显著回升，仍处于相对低位 运行阶段，市场机制将迫使一部分企业关停或转产其他产品，随着产能的逐步出清，赤藓糖醇市场有望 逐步恢复相对稳定的供需格局，产品价格也会趋于合理 ...